By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NeuroDerm Ltd. 



Ofakim      Israel
Phone: 925-270-0519 Fax: 925-290-1209


SEARCH JOBS


Industry
Pharmaceutical






Company News
NeuroDerm (NDRM) Announces Second Quarter 2017 Financial Results 8/4/2017 11:36:47 AM
NeuroDerm (NDRM) Announces Extraordinary General Meeting Of Shareholders To Approve Acquisition By Mitsubishi Tanabe 8/2/2017 11:10:26 AM
Results Of NeuroDerm (NDRM)’s ND0612H Phase II Trial Presented In Oral Session At The 3rd Congress Of The European Academy Of Neurology 6/27/2017 11:14:08 AM
NeuroDerm (NDRM) Presents Six Posters At The 21st International Congress Of Parkinson’s Disease And Movement Disorders 6/8/2017 10:28:58 AM
EMA Accepts Design Of NeuroDerm (NDRM)'s ND0612 Phase III Indigo Efficacy Trial 6/6/2017 7:24:17 AM
NeuroDerm (NDRM) Presents ND0612H Phase II Trial Results In Late-Breaking Poster Session At The 21st International Congress Of Parkinson’s Disease And Movement Disorders 6/5/2017 10:54:21 AM
NeuroDerm (NDRM) ND0612H Phase II Trial Results To Be Presented In Late-Breaking Session At The 21st International Congress Of Parkinson’s Disease And Movement Disorders 5/23/2017 11:06:31 AM
NeuroDerm (NDRM) Announces First Quarter 2017 Financial Results 5/11/2017 11:24:24 AM
NeuroDerm (NDRM) To Host Investor Day On April 21, 2017 4/10/2017 10:50:08 AM
NeuroDerm (NDRM) Announces Fourth Quarter And Full Year 2016 Financial Results 3/30/2017 11:19:47 AM
12345678
//-->